[Superficial pemphigus during the treatment of rheumatoid polyarthritis with D-penicillamine and piroxicam (Feldene)].
The authors report a new case of induced pemphigus: a 64-year-old man has had rheumatoid arthritis for 10 years. When he developed his pemphigus, he had been taking D-penicillamine and piroxicam for about 8 months. He needed high doses of prednisolone associated with azathioprine to clear his eruption. The case had a fatal outcome.
D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000188:drug therapy; D001241:Aspirin / Q000627:therapeutic use; D001379:Azathioprine / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D008875:Middle Aged; D010392:Pemphigus / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology; D010396:Penicillamine / Q000009:adverse effects*; D010894:Piroxicam; D011239:Prednisolone / Q000008:administration & dosage; D013843:Thiazines / Q000009:adverse effects*; D013997:Time Factors
D000893:Anti-Inflammatory Agents; D013843:Thiazines; D010894:Piroxicam; D011239:Prednisolone; D010396:Penicillamine; D001379:Azathioprine; D001241:Aspirin
Pemphigus superficiel apparu lors du traitement d'une polyarthrite rhumatoïde par D-pénicillamine et piroxicam (Feldène).